A promising experimental oseimer's drug and experimental elileni drug, failed its first clinical failing to meet andguls in a pivotal study. The drug did not prove effective at slowing memory loss. Experts say this is a big blow to a theory that alsheimer is caused at least in part by brain plac so it's not working as well as we would want it to work.
For decades, Alzheimer’s researchers have been stubbornly pursuing a single theory, but they’re starting to wonder: is this narrow focus the reason we still don’t have a cure?
For more, go to http://vox.com/unexplainable
It’s a great place to sign up for our newsletter, view show transcripts, and read more about the topics on our show.
Also, email us! unexplainable@vox.com
We read every email.
Support Unexplainable by making a financial contribution to Vox! bit.ly/givepodcasts
Learn more about your ad choices. Visit podcastchoices.com/adchoices